Stefania Barruscotti

9PUBLICATIONS
65CO-AUTHORS
AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Disease surveillanceMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results.

Bianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni

|Sep 09, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study.

B M Piraccini, F Pampaloni, S Cedirian

|Jul 19, 2020
Emergency accesses in Dermatology Department during the Covid-19 pandemic in a referral third level center in the north of Italy.

Eugenio Isoletta, Camilla Vassallo, Valeria Brazzelli

|Mar 28, 2018
Pediatric Old World cutaneous leishmaniasis treated with oral fluconazole: A case series.

Andrea Michelerio, Stefania Barruscotti, Grazia Bossi

Pageof 2